BioNexus Gene Lab Corp Common stock (BGLC) had the best quarter in 2021 by a US stock in Q1 2021, returning 10,956,421.7%.

ASSET	QUARTER	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	Q1 2021	10,956,421.74%
Guardforce AI (GFAI)	Q3 2021	743,561.97%
MDxHealth SA ADR (MDXH)	Q4 2021	679,900%
Synergy CHC Corp Common Stock (SNYR)	Q3 2021	8,471.43%
NFT (MI)	Q1 2021	2,400%
Vivid Seats (SEAT)	Q4 2021	2,119.68%
Atlas Lithium Corporation Common Stock (ATLX)	Q1 2021	1,600%
Tian Ruixiang (TIRX)	Q1 2021	1,218.39%
Lightwave Logic (LWLG)	Q2 2021	917.61%
GameStop (GME)	Q1 2021	899.05%
Aemetis (AMTX)	Q1 2021	839.46%
Applied Digital (APLD)	Q2 2021	767%
Prairie Operating Co Common Stock (PROP)	Q1 2021	629.51%
Sunshine Biopharma (SBFM)	Q1 2021	614.29%
Huadi International (HUDI)	Q4 2021	614.03%
Koss (KOSS)	Q1 2021	579.46%
Cassava Sciences (SAVA)	Q1 2021	557.16%
Filana Therapeutics (FLNA)	Q1 2021	557.16%
Perpetua Resources (PPTA)	Q1 2021	542.33%
Mega Matrix (MPU)	Q3 2021	476.16%
Applied Digital (APLD)	Q1 2021	454.67%
AMC Entertainment (AMC)	Q2 2021	454.06%
The9 Ltd ADR (NCTY)	Q1 2021	446.41%
Imperial Petroleum (IMPP)	Q4 2021	435%
Trump Media & Technology (DJT)	Q4 2021	414.3%